Cleared Traditional

K162753 - RTC 26-C Inline Aerosol Adapter

K162753 is an FDA 510(k) clearance for RTC 26-C Inline Aerosol Adapter, manufactured by Instrumentation Industries, Inc.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 151-day FDA review.

K162753 · Instrumentation Industries, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2017
Decision
151d
Days
Class 2
Risk

K162753 is an FDA 510(k) clearance for the RTC 26-C Inline Aerosol Adapter. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Instrumentation Industries, Inc. (Bethel Park, US). The FDA issued a Cleared decision on February 28, 2017 after a review of 151 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Instrumentation Industries, Inc. devices

FDA 510(k) Submission Details - K162753

510(k) Number K162753 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 2016
Decision Date February 28, 2017
Days to Decision 151 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d slower than avg
Panel avg: 140d · This submission: 151d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 338
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K162753.
AirLife Misty Finity Nebulizer
K153748 · Care Fusion · May 2017
Airworks Nebulizer pe1200m
K162041 · Convexity Scientific, LLC · May 2017
Velox Nebulizer System
K162785 · Pari Respiratory Equipment, Inc. · Apr 2017
Propeller Sensor Model 2015-E
K161454 · Reciprocal Labs Corporation · Nov 2016
Hudson RCI AquaPak Sterile Prefilled Nebulizers
K153010 · Teleflexmedical, Inc. · Jul 2016
Propeller System
K152882 · Reciprocal Labs · Mar 2016